Eudesmin

Eudesmin ((-) -Eudesmin) impairs adipogenic differentiation via inhibition of S6K1 signaling pathway. Eudesmin possesses diverse therapeutic effects, including anti-tumor, anti-inflammatory, and anti-bacterial activities[1].

Product Specifications

CAS Number

[526-06-7]

Product Name Alternative

(-) -Eudesmin; Eudesmine; (-) -Eudesmine

UNSPSC

12352005

Hazard Statement

H302

Target

Ribosomal S6 Kinase (RSK)

Type

Natural Products

Related Pathways

MAPK/ERK Pathway

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Cancer; Infection; Metabolic Disease; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/eudesmin.html

Purity

99.96

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

COC(C=C(C=C1)[C@@]2([H])[C@@]3([H])[C@](CO2)([H])[C@@](C(C=C4)=CC(OC)=C4OC)([H])OC3)=C1OC

Molecular Formula

C22H26O6

Molecular Weight

386.44

Precautions

H302

References & Citations

[1]Ki Hong Nam, et al. Eudesmin Impairs Adipogenic Differentiation via Inhibition of S6K1 Signaling Pathway. Biochem Biophys Res Commun. 2018 Nov 10;505 (4) :1148-1153.